These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 17085665

  • 21. Multi-institutional validation study of carboplatin dosing formula using adjusted serum creatinine level.
    Ando M, Minami H, Ando Y, Saka H, Sakai S, Yamamoto M, Sasaki Y, Shimokata K, Hasegawa Y.
    Clin Cancer Res; 2000 Dec; 6(12):4733-8. PubMed ID: 11156227
    [Abstract] [Full Text] [Related]

  • 22. [Determination of renal function in clinical routine: which is the best method?].
    Saile P, Fiedler R, Markau S, Kuhn C, Osten B.
    Dtsch Med Wochenschr; 2007 May 18; 132(20):1093-7. PubMed ID: 17492567
    [Abstract] [Full Text] [Related]

  • 23. [Estimating renal function based on creatinine clearance: application of different formulas and correction for obese patients].
    Apperloo JJ, Gerlag PG, Beerenhout CH, Vader HL.
    Ned Tijdschr Geneeskd; 2007 May 05; 151(18):1016-23. PubMed ID: 17508688
    [Abstract] [Full Text] [Related]

  • 24. Validation of a new plasma cystatin C-based formula and the Modification of Diet in Renal Disease creatinine-based formula for determination of glomerular filtration rate.
    Sterner G, Björk J, Carlson J, Grubb A, Nyman U.
    Scand J Urol Nephrol; 2009 May 05; 43(3):242-9. PubMed ID: 19291590
    [Abstract] [Full Text] [Related]

  • 25. Determination of lowest possible creatinine in living-donor kidney renal transplant recipients based on donor kidney function.
    Sberro R, Zuber J, Froissart M, Canaud G, Prié D, Martinez F, Mamzer-Bruneel MF, Anglicheau D, Legendre C, Thervet E.
    Transplantation; 2008 Aug 27; 86(4):558-63. PubMed ID: 18724226
    [Abstract] [Full Text] [Related]

  • 26. Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer.
    Donadio C, Lucchesi A, Ardini M, Cosio S, Fanucchi A, Gadducci A.
    Ther Drug Monit; 2009 Feb 27; 31(1):63-9. PubMed ID: 19077927
    [Abstract] [Full Text] [Related]

  • 27. Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin.
    De Jonge ME, Mathôt RA, Van Dam SM, Beijnen JH, Rodenhuis S.
    Cancer Chemother Pharmacol; 2002 Sep 27; 50(3):251-5. PubMed ID: 12203108
    [Abstract] [Full Text] [Related]

  • 28. Dose-banding of carboplatin: rationale and proposed banding scheme.
    Kaestner S, Sewell G.
    J Oncol Pharm Pract; 2007 Jun 27; 13(2):109-17. PubMed ID: 17873111
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis.
    Oguri T, Shimokata T, Inada M, Ito I, Ando Y, Sasaki Y, Hasegawa Y.
    Cancer Chemother Pharmacol; 2010 Sep 27; 66(4):813-7. PubMed ID: 20563583
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin.
    Jennings S, de Lemos ML, Levin A, Murray N.
    J Oncol Pharm Pract; 2010 Jun 27; 16(2):113-9. PubMed ID: 19578094
    [Abstract] [Full Text] [Related]

  • 33. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K, Harmoinen AP, Lehtimäki TJ, Korpela MM, Mustonen JT, Saha HH.
    Nephron Clin Pract; 2008 Jun 27; 108(4):c284-90. PubMed ID: 18434750
    [Abstract] [Full Text] [Related]

  • 34. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients.
    Launay-Vacher V, Izzedine H, Rey JB, Rixe O, Chapalain S, Nourdine S, Paci A, Bourget P, Deray G.
    Med Sci Monit; 2004 May 27; 10(5):CR209-12. PubMed ID: 15114271
    [Abstract] [Full Text] [Related]

  • 35. Comparison of estimated glomerular filtration rate with estimated creatinine clearance in the dosing of drugs requiring adjustments in elderly patients with declining renal function.
    Spruill WJ, Wade WE, Cobb HH.
    Am J Geriatr Pharmacother; 2008 Aug 27; 6(3):153-60. PubMed ID: 18775390
    [Abstract] [Full Text] [Related]

  • 36. Estimation of renal function -- what is appropriate in cancer patients?
    Barraclough LH, Field C, Wieringa G, Swindell R, Livsey JE, Davidson SE.
    Clin Oncol (R Coll Radiol); 2008 Dec 27; 20(10):721-6. PubMed ID: 18995170
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED, Maiefski M, Florescu MC, Qiu F, Rupp ME.
    Pharmacotherapy; 2009 Jun 27; 29(6):649-55. PubMed ID: 19476418
    [Abstract] [Full Text] [Related]

  • 38. Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.
    Cathomas R, Klingbiel D, Geldart TR, Mead GM, Ellis S, Wheater M, Simmonds P, Nagaraj N, von Moos R, Fehr M.
    Ann Oncol; 2014 Aug 27; 25(8):1591-7. PubMed ID: 24669017
    [Abstract] [Full Text] [Related]

  • 39. Population pharmacokinetics of carboplatin in children.
    Chatelut E, Boddy AV, Peng B, Rubie H, Lavit M, Dezeuze A, Pearson AD, Roché H, Robert A, Newell DR, Canal P.
    Clin Pharmacol Ther; 1996 Apr 27; 59(4):436-43. PubMed ID: 8612389
    [Abstract] [Full Text] [Related]

  • 40. Occult renal impairment is common in patients with peripheral vascular disease and normal serum creatinine.
    Rashid ST, Salman M, Agarwal S, Hamilton G.
    Eur J Vasc Endovasc Surg; 2006 Sep 27; 32(3):294-9. PubMed ID: 16716614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.